Suven Life Sciences gets nod to raise funds up to $100 million

Suven Life Sciences has received an approval for raising of funds not exceeding $100 million or its equivalent of any other Foreign/ Indian currencies by way of issue of securities to QIPs/ FCCBs/ other modes in accordance with SEBI guidelines and subject to necessary approvals from statutory authorities as may be required. The board of directors at their meeting held on September 22, 2014 has approved for the same.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.